Viking Holdings News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.11.24	3 Things You Need to Know if You Buy Viking Therapeutics Today (MotleyFool)
17.11.24	Is It Too Late to Buy Viking Therapeutics Stock? (MotleyFool)
13.11.24	Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly? (MotleyFool)
10.11.24	Is Viking Therapeutics a Buy on the Dip? (MotleyFool)
08.11.24	4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move (MotleyFool)
07.11.24	Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag (MotleyFool)
05.11.24	Is Viking Therepautics a Buy Now? (MotleyFool)
05.11.24	Why Viking Therapeutics Stock Plummeted After Soaring Today (MotleyFool)
04.11.24	Viking Therapeutics' Reveals Early-Stage From Experimental Oral Obesity Drug Showing Weight Loss And Safety (Benzinga)
04.11.24	Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial (MarketWatch)
29.10.24	Unpacking the Latest Options Trading Trends in Viking Therapeutics (Benzinga)
28.10.24	Here's How Much $100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today (Benzinga)
24.10.24	Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday (MotleyFool)
24.10.24	Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms (MarketWatch)
22.10.24	An Overview of Viking Therapeutics's Earnings (Benzinga)
22.10.24	Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains? (Benzinga)
17.10.24	Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future (MotleyFool)
14.10.24	Where Will Viking Therapeutics Be in 5 Years? (MotleyFool)
13.10.24	Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics (MotleyFool)
10.10.24	Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years (Benzinga)
09.10.24	Viking Therapeutics Reveals Encouraging Data From Genetic Disorder Drug Study, Analyst Says Focus On Orphan Disease Broadens Viking's Potential Revenue Streams (Benzinga)
09.10.24	Viking Therapeutics reports positive data from trial of treatment for rare metabolic disorder X-ALD (MarketWatch)
08.10.24	Viking Therapeutics Unusual Options Activity (Benzinga)
01.10.24	Why Viking Therapeutics Stock Topped the Market Today (MotleyFool)
29.09.24	Is Viking Therapeutics Stock a Buy? (MotleyFool)
28.09.24	Better Rising Biotech: Viking Therapeutics vs. Summit Therapeutics (MotleyFool)
27.09.24	$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today (Benzinga)
26.09.24	Why Viking Therapeutics Stock Was So Healthy on Wednesday (MotleyFool)
24.09.24	Viking Therapeutics Unusual Options Activity For September 24 (Benzinga)
23.09.24	Amgen vs. Viking Therapeutics: What's the Better GLP-1 Stock to Buy? (MotleyFool)
21.09.24	Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today (MotleyFool)
20.09.24	Jim Cramer: Viking Has 'Many Ships Coming In' (CORRECTED) (Benzinga)
17.09.24	What the Options Market Tells Us About Viking Therapeutics (Benzinga)
15.09.24	Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. (MotleyFool)
13.09.24	Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 (MotleyFool)
13.09.24	Why Investors Plowed Into Viking Therapeutics Stock Today (MotleyFool)
11.09.24	Why Viking Therapeutics Stock Rocked the Market Today (MotleyFool)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Viking Holdings Ltd Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten